Search by Drug Name or NDC
NDC 45802-0143-03 triple antibiotic 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g Details
triple antibiotic 400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g
triple antibiotic is a TOPICAL OINTMENT in the HUMAN OTC DRUG category. It is labeled and distributed by Padagis Israel Pharmaceuticals Ltd. The primary component is BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE.
MedlinePlus Drug Summary
Neomycin, polymyxin, and bacitracin combination is used to prevent minor skin injuries such as cuts, scrapes, and burns from becoming infected. Neomycin, polymyxin, and bacitracin are in a class of medications called antibiotics. Neomycin, polymyxin, and bacitracin combination works by stopping the growth of bacteria.
Related Packages: 45802-0143-03Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Neomycin, Polymyxin, and Bacitracin Topical
Product Information
NDC | 45802-0143 |
---|---|
Product ID | 45802-143_dcf538de-596c-4411-9eb5-c27f40c5644c |
Associated GPIs | 90109803104200 |
GCN Sequence Number | 061415 |
GCN Sequence Number Description | neomycin/bacitracin/polymyxinB OINT PACK 3.5-400-5K TOPICAL |
HIC3 | Q5W |
HIC3 Description | TOPICAL ANTIBIOTICS |
GCN | 97206 |
HICL Sequence Number | 033356 |
HICL Sequence Number Description | NEOMYCIN SULFATE/BACITRACIN ZINC/POLYMYXIN B |
Brand/Generic | Brand |
Proprietary Name | triple antibiotic |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | bacitracin zinc, neomycin, polymyxin B |
Product Type | HUMAN OTC DRUG |
Dosage Form | OINTMENT |
Route | TOPICAL |
Active Ingredient Strength | 400; 3.5; 5000 |
Active Ingredient Units | [USP'U]/g; mg/g; [USP'U]/g |
Substance Name | BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE |
Labeler Name | Padagis Israel Pharmaceuticals Ltd |
Pharmaceutical Class | Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS] |
DEA Schedule | n/a |
Marketing Category | OTC MONOGRAPH FINAL |
Application Number | part333B |
Listing Certified Through | 2024-12-31 |
Package
Package Images


NDC 45802-0143-03 (45802014303)
NDC Package Code | 45802-143-03 |
---|---|
Billing NDC | 45802014303 |
Package | 1 TUBE in 1 CARTON (45802-143-03) / 28 g in 1 TUBE |
Marketing Start Date | 2014-05-20 |
NDC Exclude Flag | N |
Pricing Information | |
Price Per Unit | 0.09463 |
Pricing Unit | GM |
Effective Date | 2024-02-21 |
NDC Description | TRIPLE ANTIBIOTIC OINTMENT |
Pharmacy Type Indicator | C/I |
OTC | Y |
Explanation Code | 1, 5 |
Classification for Rate Setting | G |
As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis
Standard Product Labeling (SPL)/Prescribing Information SPL 28fff253-ddd4-4669-aa90-b4caf48c905f Details
Active ingredients (in each gram)
Warnings
Directions
Inactive ingredients
Principal Display Panel
INGREDIENTS AND APPEARANCE
TRIPLE ANTIBIOTIC
bacitracin zinc, neomycin, polymyxin b ointment |
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
Labeler - Padagis Israel Pharmaceuticals Ltd (600093611) |
Revised: 3/2022
Document Id: dcf538de-596c-4411-9eb5-c27f40c5644c
Set id: 28fff253-ddd4-4669-aa90-b4caf48c905f
Version: 6
Effective Time: 20220325